Neurotech International Limited (NTI.AX)
AUD 0.05
(-3.57%)
AUD 0.05
(-3.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | - AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | -100.0% |
| 2020 | 54.2 Thousand AUD | -57.01% |
| 2019 | 126.07 Thousand AUD | 323.24% |
| 2018 | 29.78 Thousand AUD | -92.05% |
| 2017 | 374.8 Thousand AUD | -2.8% |
| 2016 | 385.6 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - AUD | 0.0% |
| 2024 FY | - AUD | 0.0% |
| 2024 Q4 | - AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2022 Q2 | 30.09 Thousand AUD | 0.0% |
| 2021 FY | - AUD | -100.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 Q2 | 352.67 Thousand AUD | 0.0% |
| 2020 Q4 | 54.2 Thousand AUD | 0.0% |
| 2020 FY | 54.2 Thousand AUD | -57.01% |
| 2019 FY | 126.07 Thousand AUD | 323.24% |
| 2019 Q4 | 126.07 Thousand AUD | 0.0% |
| 2019 Q2 | 34.57 Thousand AUD | 0.0% |
| 2018 Q4 | 29.78 Thousand AUD | 0.0% |
| 2018 Q2 | 364.56 Thousand AUD | 0.0% |
| 2018 FY | 29.78 Thousand AUD | -92.05% |
| 2017 Q2 | 468.61 Thousand AUD | 0.0% |
| 2017 FY | 374.8 Thousand AUD | -2.8% |
| 2017 Q4 | 374.8 Thousand AUD | 0.0% |
| 2016 Q4 | 945.6 Thousand AUD | 0.0% |
| 2016 FY | 385.6 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 100.0% |
| Adherium Limited | 93.2 Thousand AUD | 100.0% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 100.0% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | 100.0% |
| Anteris Technologies Ltd | 2.33 Million AUD | 100.0% |
| Control Bionics Limited | 961.73 Thousand AUD | 100.0% |
| CardieX Limited | 3.22 Million AUD | 100.0% |
| Compumedics Limited | 6.97 Million AUD | 100.0% |
| Cochlear Limited | 243.7 Million AUD | 100.0% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 100.0% |
| Cyclopharm Limited | 4.22 Million AUD | 100.0% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 100.0% |
| Nova Eye Medical Limited | 3.34 Million AUD | 100.0% |
| HeraMED Limited | 260.65 Thousand AUD | 100.0% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 100.0% |
| ImpediMed Limited | 1.14 Million AUD | 100.0% |
| InhaleRx Limited | 560.27 Thousand AUD | 100.0% |
| LBT Innovations Limited | 1.74 Million AUD | 100.0% |
| Micro-X Limited | 4.05 Million AUD | 100.0% |
| OncoSil Medical Limited | 70.67 Thousand AUD | 100.0% |
| PolyNovo Limited | 15.38 Million AUD | 100.0% |
| Respiri Limited | 1.17 Million AUD | 100.0% |
| SomnoMed Limited | 1.01 Million AUD | 100.0% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 100.0% |
| Uscom Limited | 989.27 Thousand AUD | 100.0% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | 100.0% |